Supporting Innovation and Entrepreneurship for more than 60 years

Welcome to Safeguard Scientifics' Blog, where we share Perspective, Strategy and Insight.

Archive: Life Sciences

Corporate

Safeguard Announces Final Agenda and Webcast for Investor Day 2013

Safeguard announced the final agenda and webcast information for Investor Day 2013. The event will be held at the New York Stock Exchange tomorrow, October 8, 2013 from 8:00 a.m. to 11:45 a.m. EDT.   AGENDA 8:00 a.m. — Registration and Breakfast 8:30 a.m. — Opening Remarks Stephen T. Zarrilli, President and CEO, Safeguard 8:45 a.m. — Specialty Pharmaceuticals Putney,…

Read more

Investor Day

Safeguard Scientifics Announces Details for 7th Annual Investor Day

SAVE THE DATE! Safeguard Scientifics will be hosting its 7th Annual Investor Day at the New York Stock Exchange on Tuesday, October 8, 2013 from 8:00 a.m. – 11:30 a.m. EDT. Investor Day 2013 will offer the investor community an opportunity to hear from executives from Safeguard’s partner companiesabout growth opportunities and value creation strategies. Partner companies that are currently scheduled to present include,…

Read more

Life Sciences

3 Ways Diagnostics Can Cut Healthcare Costs and Improve Patient Outcomes

According to the Institute of Medicine, $750 billion in healthcare spending was wasted in 2009. And while its rate of growth has slowed, healthcare spending remains a major concern. That’s why opportunities abound for companies with new products and services that can improve patient outcomes and trim costs. One emerging technology is actionable diagnostics, an innovative new approach to medicine.…

Read more

A Look Ahead

A Look Ahead: Windows 8, Surface Tablet to Debut on the Heels of the iPad Mini

If you thought September was a big month for technology announcements with the iPhone 5, new Kindles, and other tablets and phones creating mobile opportunities for startups, wait until you see what’s on tap in the next couple weeks. Next week, many media suspect Apple will debut the new iPad mini on Oct. 23 to compete directly with tablets from…

Read more

Life Sciences

Anatomy of a Deal: Avid Radiopharmaceuticals

This morning, I presented at the 2012 Annual RBC Biotech Conference, which focused on the “Biotech Success Stories of the [Philadelphia] Region”. I was asked to speak about Safeguard’s success with our life sciences partner company, Avid Radiopharmaceuticals, which was acquired in December 2012 by Eli Lilly. The following presentation, entitled “The Success of Avid Pharmaceuticals from an Investor’s Point…

Read more